7th Decentralized Hybrid Clinical Trials Summit to Expand Trial Accessibility and Diversity

May 10-11, 2023 - Philadelphia, PA

DGE invites clinical innovation and development experts, patient recruitment specialists, and clinical safety/regulatory affairs officers, to attend the 7th Decentralized & Hybrid Clinical Trials Summit to be held in Philadelphia, PA, May 10-11, 2023.

Over 50% of clinical trials are likely to be decentralized by 2024.  The size of virtual clinical trial data is overtaking traditional clinical trial processes requiring an advanced data science paradigm. Getting real-time AI/ML-driven insights can help research teams cut the time and cost of clinical trials while accelerating new drugs to market.

The 7th Decentralized & Hybrid Clinical Trials Summit will focus on leveraging AI/ML insights to enable more precise decision-making in remote trials. Attendees will learn how real-time AI/ML-driven insights are enabling key workflows in DCTs and risk-based quality management (RBQM).

It’s a great opportunity to address common DCT misperceptions and mistakes. At the same time, attendees will be able to consider the impact of improving patient safety and study quality while reducing cost and time.

To learn more, please visit

Conference Highlights
  • The COVID-19 pandemic significantly disrupted the operational model of traditional clinical trials as travel restrictions and the diversion of finite health-care resources led to significant declines in trial activation, enrollment, and data collection.
  • The pressing need to continue therapeutic trials nurtured improvement in trial operations termed decentralized clinical trials.
  • Decentralized Clinical Trials (DCTs) are trials wherein elements of research conduct (drug delivery, adverse event assessments, imaging, and laboratory draws) are delivered remotely from the primary clinical trial site and closer to a patient’s home.
  • Event Website

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717

You’re already more familiar with brand awareness than you might think. What’s your favorite brand of soft drink, athletic shoe, car, shampoo, streaming content provider? Chances are, you first tried those brands because of their awareness strategies. Whether it was word of mouth or a TV commercial, Facebook post, billboard or coupon, that awareness peaked interest, triggered a purchase reaction, and ideally built customer loyalty.

More About Brand Awareness

5,000+ key syndication outlets across the country. IBN’s extensive system of strategic distribution points maximizes your exposure to an audience of millions, including journalists, investors, day traders, fund managers and a multitude of other interested individuals. Now your press releases, earnings statements, branded articles, shareholder updates, corporate achievements can reach a vast and diverse nationwide audience.

More About InvestorWire

Make sure your message resonates. IBN integrates social media with traditional distribution channels to make sure your message resonates long after initial publication. This innovative model ensures that your news not only crosses the wire, but keeps reverberating via social conversation on Twitter, Facebook, LinkedIn and other social networks.

More About Social MediaIBN Social Media NetworkSocial Media Statistics & FAQs

A unique format with a traditionally different sensory input – hearing.As conferences and events continue to suffer cancellations and greatly reduced attendance, many businesses are wondering how to network with large investor audiences in the new normal. At the same time podcasts have seen a jump in popularity.

More About IBN Podcast Solutions